Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Gross Margin (2024 - 2025)

Beta Bionics (BBNX) has disclosed Gross Margin for 2 consecutive years, with 58.98% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 179.0% to 58.98% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 55.4% through Dec 2025, up 29.0% year-over-year, with the annual reading at 55.4% for FY2025, 29.0% up from the prior year.
  • Gross Margin hit 58.98% in Q4 2025 for Beta Bionics, up from 55.48% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 58.98% in Q4 2025 to a low of 50.86% in Q1 2025.